Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 71, Number 12, September 16, 2008
Right arrow Data Supplement
Right arrow JapaneseTranslation
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graus, F.
Right arrow Articles by Dalmau, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graus, F.
Right arrow Articles by Dalmau, J.
Related Collections
Right arrow Autoimmune diseases
Right arrow Encephalitis
Right arrow Paraneoplastic syndrome
NEUROLOGY 2008;71:930-936
© 2008 American Academy of Neurology

Neuronal surface antigen antibodies in limbic encephalitis

Clinical–immunologic associations

F. Graus, MD, A. Saiz, MD, M. Lai, MD, J. Bruna, MD, F. López, MD, L. Sabater, PhD, Y. Blanco, MD, M. J. Rey, MD, T. Ribalta, MD and J. Dalmau, MD, PhD

From the Service of Neurology (F.G., A.S., F.L., L.S., Y.B.), Hospital Clinic and Institut d’ Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Neurology (M.L., J.D.), University of Pennsylvania, Philadelphia; Service of Neurology (J.B.), C.S.U. Bellvitge, Hospitalet, Spain; and Brain Tissue Bank (M.J.R., T.R.), University of Barcelona, Hospital Clínic, Spain.

Address correspondence and reprint requests to Dr. Francesc Graus, Servei de Neurologia, Hospital Clínic, Villarroel 170, Barcelona 08036, Spain fgraus{at}clinic.ub.es

Objective: To report the frequency and type of antibodies against neuronal surface antigens (NSA-ab) in limbic encephalitis (LE).

Methods: Analysis of clinical features, neuropathologic findings, and detection of NSA-ab using immunochemistry on rat tissue and neuronal cultures in a series of 45 patients with paraneoplastic (23) or idiopathic (22) LE.

Results: NSA-ab were identified in 29 patients (64%; 12 paraneoplastic, 17 idiopathic). Thirteen patients had voltage-gated potassium channels (VGKC)-ab, 11 novel NSA (nNSA)-ab, and 5 NMDA receptor (NMDAR)-ab. nNSA-ab did not identify a common antigen and were more frequent in paraneoplastic than idiopathic LE (39% vs 9%; p = 0.03). When compared with VGKC-ab or NMDAR-ab, the nNSA associated more frequently with intraneuronal antibodies (11% vs 73%; p = 0.001). Of 12 patients (9 nNSA-ab, 2 VGKC-ab, 1 NMDAR-ab) with paraneoplastic LE and NSA-ab, concomitant intraneuronal antibodies occurred in 9 (75%). None of these 12 patients improved with immunotherapy. The autopsy of three of them showed neuronal loss, microgliosis, and cytotoxic T cell infiltrates in the hippocampus and amygdala. These findings were compatible with a T-cell mediated neuronal damage. In contrast, 13 of 17 (76%) patients with idiopathic LE and NSA-ab (8 VGKC-ab, 4 NMDAR-ab, 1 nNSA-ab) and 1 of 5 (20%) without antibodies had clinical improvement (p = 0.04).

Conclusions: In paraneoplastic limbic encephalitis (LE), novel antibodies against neuronal surface antigens (nNSA-ab) occur frequently, coexist with antibodies against intracellular antigens, and these cases are refractory to immunotherapy. In idiopathic LE, the likelihood of improvement is significantly higher in patients with NSA-ab than in those without antibodies.

GLOSSARY: GAD = glutamic acid decarboxylase; LE = limbic encephalitis; NMDAR = N-methyl-D-aspartate receptor; NSA = neuronal surface antigens; nNSA = novel NSA; SCLC = small-cell lung cancer; VGKC = voltage-gated potassium channels; WBC = white blood cells.

Supplemental data at www.neurology.org

Supported in part by grants PI030028 Fondo de Investigaciones Sanitarias, Madrid, Spain (F.G.), and National Cancer Institute/National Institute of Health, RO1CA107192 (J.D.).

Disclosure: The authors report no disclosures.

Received March 29, 2008. Accepted in final form June 13, 2008.




This article has been cited by other articles:


Home page
 Arch NeurolHome page
P. Niehusmann, J. Dalmau, C. Rudlowski, A. Vincent, C. E. Elger, J. E. Rossi, and C. G. Bien
Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women With New-Onset Epilepsy
Arch Neurol, April 1, 2009; 66(4): 458 - 464.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.